Patents by Inventor Jorge Alsina-Fernandez

Jorge Alsina-Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080096811
    Abstract: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
    Type: Application
    Filed: May 19, 2005
    Publication date: April 24, 2008
    Applicant: Eli Lilly and Company
    Inventors: Bengt Krister Bokvist, Jesper Lindgren Gromada, Robert Chadwick Cummins, Wolfgang Glaesner, John Philip Mayer, Lianshan Zhang, Jorge Alsina-Fernandez
  • Publication number: 20080085860
    Abstract: The present invention encompasses PEGylated peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
    Type: Application
    Filed: August 11, 2005
    Publication date: April 10, 2008
    Applicant: ELI LILLY AND COMPANY
    Inventors: Bengt Krister Bokvist, John Phillip Mayer, Lianshan Zhang, Jorge Alsina-Fernandez, Andrew Mark Vick
  • Publication number: 20080026996
    Abstract: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
    Type: Application
    Filed: May 19, 2005
    Publication date: January 31, 2008
    Applicant: ELI LILLY AND COMPANY
    Inventors: Bengt Bokvist, Jesper Gromada, Robert Cummins, Wolfgang Glaesner, John Mayer, Lianshan Zhang, Jorge Alsina-Fernandez